These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 27435909)

  • 1. Chronic administration of aripiprazole activates GSK3β-dependent signalling pathways, and up-regulates GABAA receptor expression and CREB1 activity in rats.
    Pan B; Huang XF; Deng C
    Sci Rep; 2016 Jul; 6():30040. PubMed ID: 27435909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aripiprazole and Haloperidol Activate GSK3β-Dependent Signalling Pathway Differentially in Various Brain Regions of Rats.
    Pan B; Huang XF; Deng C
    Int J Mol Sci; 2016 Mar; 17(4):459. PubMed ID: 27043526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aripiprazole Increases the PKA Signalling and Expression of the GABAA Receptor and CREB1 in the Nucleus Accumbens of Rats.
    Pan B; Lian J; Huang XF; Deng C
    J Mol Neurosci; 2016 May; 59(1):36-47. PubMed ID: 26894264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation by chronic antipsychotic administration of PKA- and GSK3β-mediated pathways and the NMDA receptor in rat ventral midbrain.
    Pan B; Deng C
    Psychopharmacology (Berl); 2019 Sep; 236(9):2687-2697. PubMed ID: 31053935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unique Effects of Acute Aripiprazole Treatment on the Dopamine D2 Receptor Downstream cAMP-PKA and Akt-GSK3β Signalling Pathways in Rats.
    Pan B; Chen J; Lian J; Huang XF; Deng C
    PLoS One; 2015; 10(7):e0132722. PubMed ID: 26162083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic antipsychotic treatment differentially modulates protein kinase A- and glycogen synthase kinase 3 beta-dependent signaling pathways, N-methyl-D-aspartate receptor and γ-aminobutyric acid A receptors in nucleus accumbens of juvenile rats.
    Pan B; Lian J; Deng C
    J Psychopharmacol; 2018 Nov; 32(11):1252-1263. PubMed ID: 30136620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Partial agonist properties of the antipsychotics SSR181507, aripiprazole and bifeprunox at dopamine D2 receptors: G protein activation and prolactin release.
    Cosi C; Carilla-Durand E; Assié MB; Ormiere AM; Maraval M; Leduc N; Newman-Tancredi A
    Eur J Pharmacol; 2006 Mar; 535(1-3):135-44. PubMed ID: 16554049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aripiprazole and haloperidol protect neurite lesions via reducing excessive D2R-DISC1 complex formation.
    Zheng P; Hu M; Xie Y; Yu Y; Jaaro-Peled H; Huang XF
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Jun; 92():59-69. PubMed ID: 30597182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bifeprunox and aripiprazole suppress in vivo VTA dopaminergic neuronal activity via D2 and not D3 dopamine autoreceptor activation.
    Etievant A; Bétry C; Arnt J; Haddjeri N
    Neurosci Lett; 2009 Aug; 460(1):82-6. PubMed ID: 19450663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deletion of GSK3β in D2R-expressing neurons reveals distinct roles for β-arrestin signaling in antipsychotic and lithium action.
    Urs NM; Snyder JC; Jacobsen JP; Peterson SM; Caron MG
    Proc Natl Acad Sci U S A; 2012 Dec; 109(50):20732-7. PubMed ID: 23188793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of short- and long-term aripiprazole treatment on Group I mGluRs in the nucleus accumbens: Comparison with haloperidol.
    Lum JS; Pan B; Deng C; Huang XF; Ooi L; Newell KA
    Psychiatry Res; 2018 Feb; 260():152-157. PubMed ID: 29195167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aripiprazole, a novel antipsychotic drug, preferentially increases dopamine release in the prefrontal cortex and hippocampus in rat brain.
    Li Z; Ichikawa J; Dai J; Meltzer HY
    Eur J Pharmacol; 2004 Jun; 493(1-3):75-83. PubMed ID: 15189766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of bifeprunox and aripiprazole on rat serotonin and dopamine neuronal activity and anxiolytic behaviour.
    Dahan L; Husum H; Mnie-Filali O; Arnt J; Hertel P; Haddjeri N
    J Psychopharmacol; 2009 Mar; 23(2):177-89. PubMed ID: 18515444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different effects of bifeprunox, aripiprazole, and haloperidol on body weight gain, food and water intake, and locomotor activity in rats.
    De Santis M; Pan B; Lian J; Huang XF; Deng C
    Pharmacol Biochem Behav; 2014 Sep; 124():167-73. PubMed ID: 24933333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The antipsychotics clozapine and olanzapine increase plasma glucose and corticosterone levels in rats: comparison with aripiprazole, ziprasidone, bifeprunox and F15063.
    Assié MB; Carilla-Durand E; Bardin L; Maraval M; Aliaga M; Malfètes N; Barbara M; Newman-Tancredi A
    Eur J Pharmacol; 2008 Sep; 592(1-3):160-6. PubMed ID: 18640111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Temporal and spatial transcriptional fingerprints by antipsychotic or propsychotic drugs in mouse brain.
    Sakuma K; Komatsu H; Maruyama M; Imaichi S; Habata Y; Mori M
    PLoS One; 2015; 10(2):e0118510. PubMed ID: 25693194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of antipsychotic drugs on BDNF, GSK-3β, and β-catenin expression in rats subjected to immobilization stress.
    Park SW; Phuong VT; Lee CH; Lee JG; Seo MK; Cho HY; Fang ZH; Lee BJ; Kim YH
    Neurosci Res; 2011 Dec; 71(4):335-40. PubMed ID: 21893111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contrasting contribution of 5-hydroxytryptamine 1A receptor activation to neurochemical profile of novel antipsychotics: frontocortical dopamine and hippocampal serotonin release in rat brain.
    Assié MB; Ravailhe V; Faucillon V; Newman-Tancredi A
    J Pharmacol Exp Ther; 2005 Oct; 315(1):265-72. PubMed ID: 15987834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discriminative stimulus properties of S32504, a novel D3/D2 receptor agonist and antiparkinson agent, in rats: attenuation by the antipsychotics, aripiprazole, bifeprunox, N-desmethylclozapine, and by selective antagonists at dopamine D2 but not D3 receptors.
    Millan MJ; Iob L; Péglion JL; Dekeyne A
    Psychopharmacology (Berl); 2007 Apr; 191(3):767-82. PubMed ID: 17047933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pretreatment of aripiprazole and minocycline, but not haloperidol, suppresses oligodendrocyte damage from interferon-γ-stimulated microglia in co-culture model.
    Seki Y; Kato TA; Monji A; Mizoguchi Y; Horikawa H; Sato-Kasai M; Yoshiga D; Kanba S
    Schizophr Res; 2013 Dec; 151(1-3):20-8. PubMed ID: 24100191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.